Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections (LRTIs) in infants. Most deaths occur in infants under 3 months old, and those living in low and middle-income countries (LMICs). There are no maternal or infant RSV vaccines currently approved. An RSV...

Descripción completa

Detalles Bibliográficos
Autores principales: Ananworanich, Jintanat, Heaton, Penny M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473431/
https://www.ncbi.nlm.nih.gov/pubmed/34579198
http://dx.doi.org/10.3390/vaccines9090961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473431/
https://www.ncbi.nlm.nih.gov/pubmed/34579198
http://dx.doi.org/10.3390/vaccines9090961

Ejemplares similares